Venture Capital

With a new $200M funding round, legal AI leader Harvey is now valued at $11 billion, signaling a fundamental shift in how law is practiced worldwide.

With a new $20M in funding, Charlotte-based Lucid Bots is expanding its fleet of AI-powered drones and robots, transforming blue-collar work from the ground up.

From the heart of Arabia, AlUla Peregrina brings a patented active to the global stage, promising scientifically-backed, ethical longevity beauty.

With the appointment of Wayne Grierson, Tixr is accelerating its push to disrupt Europe's legacy ticketing market with its modern commerce platform.

Struggling in the furniture market, XMax Inc. is making a bold leap into AI. But can a small furniture firm compete with tech giants?

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

Venture capital leaders and national security experts caution that drug pricing controls and regulatory hurdles could cede America's biomedical edge to rivals.

With its AI 'teammate' Harper, Wisq is automating HR tasks, pushing the profession from administrative burden to a strategic business powerhouse.

Serial entrepreneur Brett Adcock's new venture, Hark, aims to build the next computing platform with custom hardware and backing from NVIDIA and Apple talent.

Agtech leader Halter lands a massive $220M funding round, fueling a global push for its AI-powered virtual fencing that is transforming livestock farming.

Sequoia Group launches 'Pages,' a collaborative workspace, and its 2026 report to help firms navigate rising costs, AI talent wars, and compensation.

A surprise brain cancer diagnosis led Arun Verma to build Triangle Health, an AI platform with a doctor-in-the-loop to help patients navigate complex illness.

Venture firm Sonder Capital closes its new fund with backing from Mayo Clinic and Sutter Health, aiming to revolutionize patient care with AI-powered robotics.

As oncologists warn of supplement risks, one company founded by a doctor and caregiver aims to provide a safer, transparent path for cancer survivors.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

GoNetspeed is investing $13.6M to bring multi-gigabit fiber internet to South River, sparking new competition and future-proofing the NJ borough.

Doctronic's AI can now legally renew prescriptions. Its massive new funding signals a new era in healthcare, but experts are raising serious safety concerns.

A Vancouver firm's revolutionary tech, backed by government funds, aims to decarbonize metal recovery and secure North America's platinum supply chain.

The scientist behind PARP inhibitors is backing a new approach. Dr. Alan Ashworth's appointment at Leapfrog Bio signals a major push in precision oncology.

Attending a science workshop and a power conference, the OTC-listed firm signals its push to bridge the gap between lab theory and grid reality.